Cite
APA Citation
Lik Yuen Chan, H., Seto, W. K., Buti, M., Izumi, N., Lim, Y., Kao, J., Streinu-Cercel, A., Nurmukhametova, E., Ma, X., Tabak, F., Jablkowski, M., Suri, V., Flaherty, J., Lau, A., Gaggar, A., Mo, S., Chowdhury, A., Fung, S., Chuang, W., & Gane, E. (n.d.). iDDF2019-ABS-0168 Bone and renal safety are improved in chronic hbv patients 1 year after switching to tenofovir alafenamide (TAF) from tenofovir disoproxil fumarate (TDF). Gut, 68, A141. http://access.bl.uk/ark:/81055/vdc_100144712450.0x00003b